ANTIPLAQUE INGREDIENT REVIEW BY FDA'S PLAQUE SUBCOMMITTEE
This article was originally published in The Tan Sheet
Executive Summary
ANTIPLAQUE INGREDIENT REVIEW BY FDA'S PLAQUE SUBCOMMITTEE will initially include 12 single ingredients and four combinations, OTC Plaque Products Subcommittee Acting Chair Robert Genco, DDS/PhD, State University of New York School of Medicine, reported at a June 28-29 meeting. The subcommittee is charged with reviewing the safety and efficacy and risk/benefit of antiplaque ingredients ("The Tan Sheet" Aug. 9, 1993, p. 1). Genco said the committee plans to review single ingredients when used in combination products at a later date.